- Home
- ROIV vs PNFP Comparison
ROIV vs PNFP Comparison
Compare ROIV & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PNFP
- Stock Information
- Founded
- ROIV 2014
- PNFP 2000
- Country
- ROIV United Kingdom
- PNFP United States
- Employees
- ROIV N/A
- PNFP 3517
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PNFP Major Banks
- Sector
- ROIV Health Care
- PNFP Finance
- Exchange
- ROIV Nasdaq
- PNFP Nasdaq
- Market Cap
- ROIV 8.4B
- PNFP 9.5B
- IPO Year
- ROIV N/A
- PNFP N/A
- Fundamental
- Price
- ROIV $11.83
- PNFP $122.46
- Analyst Decision
- ROIV Strong Buy
- PNFP Buy
- Analyst Count
- ROIV 9
- PNFP 12
- Target Price
- ROIV $17.69
- PNFP $107.42
- AVG Volume (30 Days)
- ROIV 4.5M
- PNFP 515.6K
- Earning Date
- ROIV 11-12-2024
- PNFP 01-14-2025
- Dividend Yield
- ROIV N/A
- PNFP 0.71%
- EPS Growth
- ROIV N/A
- PNFP N/A
- EPS
- ROIV 5.89
- PNFP 5.24
- Revenue
- ROIV $129,128,999.00
- PNFP $1,550,522,000.00
- Revenue This Year
- ROIV $48.37
- PNFP N/A
- Revenue Next Year
- ROIV $13.76
- PNFP $13.32
- P/E Ratio
- ROIV $2.01
- PNFP $23.55
- Revenue Growth
- ROIV 145.68
- PNFP N/A
- 52 Week Low
- ROIV $8.61
- PNFP $70.23
- 52 Week High
- ROIV $13.06
- PNFP $129.39
- Technical
- Relative Strength Index (RSI)
- ROIV 51.97
- PNFP 65.41
- Support Level
- ROIV $11.05
- PNFP $120.48
- Resistance Level
- ROIV $12.05
- PNFP $125.32
- Average True Range (ATR)
- ROIV 0.30
- PNFP 3.68
- MACD
- ROIV -0.02
- PNFP -0.06
- Stochastic Oscillator
- ROIV 61.86
- PNFP 74.64
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PNFP Pinnacle Financial Partners Inc.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. Pinnacle operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.